Related references
Note: Only part of the references are listed.Identification of in vitro and in vivo oncolytic effect in colorectal cancer cells by Orf virus strain NA1/11
Daxiang Chen et al.
ONCOLOGY REPORTS (2021)
Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization
Annouk S. Pierik et al.
CANCERS (2021)
Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model
Shyambabu Chaurasiya et al.
ONCOIMMUNOLOGY (2020)
A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
Jahangir Ahmed et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment
Vivian Weiwen Xue et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Photoactivatable oncolytic adenovirus for optogenetic cancer therapy
Yasuko Hagihara et al.
CELL DEATH & DISEASE (2020)
Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
June Kyu Hwang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade
Yang Liu et al.
CELL DEATH & DISEASE (2020)
Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
Bharat Burman et al.
CANCERS (2020)
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
Elaine Y. Chung et al.
CLINICAL CANCER RESEARCH (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer
Tania D. F. Costa et al.
NATURE COMMUNICATIONS (2019)
Orf virus: A promising new therapeutic agent
Ruixue Wang et al.
REVIEWS IN MEDICAL VIROLOGY (2019)
From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
Volker Schirrmacher
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma
Hiroshi Nakashima et al.
CLINICAL CANCER RESEARCH (2018)
Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
Nikolas Tim Martin et al.
MOLECULAR THERAPY (2018)
Rethinking neoadjuvant chemotherapy for breast cancer
Jayant Vaidya et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Rethinking neoadjuvant chemotherapy for breast cancer
Jayant Vaidya et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Devalingam Mahalingam et al.
CANCERS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy (vol 170, 1109.e1, 2017)
Antoni Ribas et al.
CELL (2018)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Inhibition of neuroblastoma proliferation by PF-3758309, a small-molecule inhibitor that targets p21-activated kinase 4
Zhiheng Li et al.
ONCOLOGY REPORTS (2017)
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs
Michael C. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma
Haipeng Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Newcastle disease virus-like particles induce DC maturation through TLR4/NF-κB pathway and facilitate DC migration by CCR7-CCL19/CCL21 axis
Jing Qian et al.
VETERINARY MICROBIOLOGY (2017)
Simvastatin Ameliorates PAK4 Inhibitor-Induced Gut and Lung Injury
Shuming Pan et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Orf Virus 002 Protein Targets Ovine Protein S100A4 and Inhibits NF-κB Signaling (vol 7, 1389, 2016)
Daxiang Chen et al.
FRONTIERS IN MICROBIOLOGY (2017)
Oncolytic Viruses in Cancer Treatment A Review
Sean E. Lawler et al.
JAMA ONCOLOGY (2017)
The voltage gated Ca2+-channel Cav3.2 and therapeutic responses in breast cancer
Elena Pera et al.
CANCER CELL INTERNATIONAL (2016)
Immunogenic cell death by oncolytic herpes simplex virus type 1 in squamous cell carcinoma cells
A. Takasu et al.
CANCER GENE THERAPY (2016)
A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1
Kai Li et al.
ONCOTARGET (2016)
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
W. Shen et al.
BLOOD (2015)
Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma
Douglas B. Johnson et al.
IMMUNOTHERAPY (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
Sara M. Tolaney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy
Ninh M. La-Beck et al.
PHARMACOTHERAPY (2015)
High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells
Yuexin Zhou et al.
NATURE (2014)
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers
Yuan Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum
Arjun K. Ravi et al.
RESPIRATORY RESEARCH (2014)
Preventing Postoperative Metastatic Disease by Inhibiting Surgery-Induced Dysfunction in Natural Killer Cells
Lee-Hwa Tai et al.
CANCER RESEARCH (2013)
Oncolytic viruses as therapeutic cancer vaccines
David L. Bartlett et al.
MOLECULAR CANCER (2013)
The N Terminus of Orf Virus-Encoded Protein 002 Inhibits Acetylation of NF-κB p65 by Preventing Ser276 Phosphorylation
Zhangyong Ning et al.
PLOS ONE (2013)
Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models
Todd M. Pitts et al.
FRONTIERS IN PHARMACOLOGY (2013)
Tumor P-glycoprotein correlates with efficacy of PF-3758309 in in vitro and in vivo models of colorectal cancer
Erica Lynn Bradshaw-Pierce et al.
FRONTIERS IN PHARMACOLOGY (2013)
Isolation and phylogenetic analysis of orf virus from the sheep herd outbreak in northeast China
Wei Li et al.
BMC VETERINARY RESEARCH (2012)
Oncolytic Virus-initiated Protective Immunity Against Prostate Cancer
Shashi A. Gujar et al.
MOLECULAR THERAPY (2011)
Ki67 in breast cancer: prognostic and predictive potential
Rinat Yerushalmi et al.
LANCET ONCOLOGY (2010)
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth
Brion W. Murray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Share Paper
